chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis. No Medical History information was reported. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. In 2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). In 2021, CHILLS (Chills) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: liver level was high. On an unknown date, Hepatic enzyme: Elevated. No concomitant medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the event of Chills was not provided and the reporter's causality for the event of fatigue was no reasonable possibility with HUMIRA(ADALIMUMAB). No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Information has been received from a physician concerning a female who was vaccinated with a dose of Zostavax (Oka/Merck).  Subsequently the patient experienced allergic local reaction.  Unspecified medical attention was sought.  No further information is available.  There was no product quality complaint.  Additional information has been requested.
On March 3, 2021 the day I received the shot I did experience light-headedness and headache within 15 minutes.  However, over the course of the week I felt back pain on my left side.  Also by my left breast felt swollen.  Those symptoms eased up.  On March 10, 2021 a week later exactly at the injection site it started to swell and itch.  It was accompanied with pain and tingling.  It concerned me to the point that I went to my general practitioner in the morning on 03/12/2020.  He sated to take Tylenol and Benadryl and no steroids which will decrease the immune system.  He also said to follow up with the numbers on the card I received from the vaccine site.
My left arm went numb and then started throbbing a few hours after the injection. Then my left wrist had persistent wrist pain for a few months.
3 to 4 days after shot.  Chills, fever, neck aches, sore throat, nausea, diarrhea.  11-29- still lingering with MR.
A few weeks after vaccine I started getting extremely swollen and was having trouble breathing and my chest was hurting. I had several ER visits and I?ve seen numerous doctors. My face, hand feet, fingers were swelling on a regular basis.
Vaccine that administered beyond use date after the thaw process/expired vaccine administered; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 18-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 46 years 7 months.  No concomitant medication information was provided. On 10-Jun-2022, medical was notified about an audit that was done and they were then made aware of vaccines that were administered beyond use date after the thaw process. Patient got Moderna with vaccine Ndc code. Reporter stated that there was no patient that had any adverse reactions and there were no reports of any reactions after the administration of vaccines. No treatment medication were provided.
Headache, nausea, blurred vision, dizziness, right leg pain, tiredness.
Swelling in the arm; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in the arm), HEADACHE (headache) and MYALGIA (Body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical History information was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling in the arm), HEADACHE (headache) and MYALGIA (Body aches). At the time of the report, PERIPHERAL SWELLING (swelling in the arm), HEADACHE (headache) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not provided by the reporter. Treatment medication were not provided by the reporter.
I was 27 weeks pregnant on July 20th 2021.  I noticed the baby wasn't moving inside.  I went to my doctors office to see Dr. and that when he determined that there was not heart beat we did a ultra sound to confirm.MY DAUGHTER DIDNT MAKE IT.   I had to then go to Hospital to deliver my baby.  The process started on July 20th 2021 and I delivered my STILLBORN daughter on Thursday July 22nd.  MY due Date was OCTOBER 17TH.  the baby weighed 2 pounds and was 15 inches long.
Woke the morning  of March 18th with tenderness, warmth and mild induration at my post 9 day Pfizer Covid vaccine injection site, so of course googled it, and came upon an article regarding late reaction following Covid vaccine.  My second dose is scheduled for April 6th (do not know why they scheduled it for 28 days vs. 21) and intend on receiving it, as suggested in the article.  54 y.o. female  History seasonal allergies, hives with sulfa and clindamycin Dose 1 - received March 9th  - Day 9 reaction (no reaction immediately post vaccine) Left arm Local symptoms - tenderness, warmth, mild induration Size - 6cm X 4cm Systemic symptoms - mild malaise Treatment - 3 Advil and 50mg of Benadryl
Day of vaccination: Headache, extreme fatigue, whole body muscle ache, chills, fever Day 2: headache, fatigue, chills Day 3: chills, headache, nausea and vomiting Day 4 to currently still ongoing: headache, nausea and vomiting
After the shot became pale and had jerking movement twice and passed out. Also urinated. Lasted 15 seconds.
Patient's left upper arm where vaccination was given had localized redness, swelling, and warmth to touch. Patient denied pain but reported that site was painful for 2 days after receiving vaccination. Patient was encouraged to apply warm/cool packs and to notify provide if signs/symptoms do not resolve. Injection site reactions.
ARMPIT SWELLING; ARMPIT PAIN; SORE ACROSS THE SHOULDER; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 (Vaccinated in left arm) for prophylactic vaccination. No concomitant medications were reported. On 28-MAR-2021, the subject experienced armpit swelling. On 28-MAR-2021, the subject experienced armpit pain. On 28-MAR-2021, the subject experienced sore across the shoulder. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the armpit swelling, armpit pain and sore across the shoulder was not reported. This report was non-serious.
Pt had allergic reaction to Zostavax shot. Described as whole arm being red and itchiing, spreading upwards to neck.
Patient was given his first Pfizer Pediatrics dose today and we didn't realize that it expired on 9/30/2022, so he received an expired vaccine.  We are not aware of him experiencing any adverse effects/events from it.
Pt seen @ clinic 12NOV91 c/o vomiting x 2 that AM & t102; Dx'd w/APAP, cl liquids, requested to come 13NOV to provide UA to RN UTI, did not return 13NOV
muscle/joint aches; Shakey/jittery; jittery; rapid heart rate; Fever of 103.8; Chills; muscle/joint aches; This is a spontaneous report from a contactable female nurse reported for herself (Non pregnant). A 43-year-old female patient(nurse) received second dose of BNT162B2 (Solution for injection, lot number: unknown) via left arm on 28Jan2021, 15:00 PM, single dose for COVID-19 Immunization. Patients receive other vaccines within 4 weeks prior to the COVID vaccine the patient took other historical vaccine included first dose BNT162B2 (lot number: Unknown) on 07Jan2021, at single Covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered in Hospital. The patient received other vaccines within 4 weeks prior to the COVID. Patient had allergies to medications Bactrim.
Was fine then pain in groin ,cold white leg called ambulance had clot from groin to below knee. Heart ejection fraction 32%
big round circle around the injection site. It was puffed up and red; big round circle around the injection site. It was puffed up and red; This case was reported by a other health professional via call center representative and described the occurrence of injection site swelling in a female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2020-2021 season) (batch number Z5N5G, expiry date 30th June 2021) for prophylaxis.   On 17th September 2020, the patient received Fluarix Quadrivalent 2020-2021 season. On 17th September 2020, less than a day after receiving Fluarix Quadrivalent 2020-2021 season, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to Fluarix Quadrivalent 2020-2021 season.  Additional details were reported as follows: The age at vaccination not reported. The patient received Fluarix Quadrivalent 2020-2021 season and experienced a big round circle around the injection site,It was puffed up and red,which is recovered. The reporter consented to follow up. The reporter did not provided any other information. This case was linked with case id US2020189720 and US2020189733 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020189720:same reporter US-GLAXOSMITHKLINE-US2020189733:same reporter
Pt was experiencing severe chest pain and thought she might be having a heart attack. She went to the hospital and was admitted. During admission, they gave her a COVID test and she tested positive. Since then, other symptoms included headaches, chills, congestion. She also experienced dizziness (difficult to walk or sit up), ringing in my ears, massive headache. She went to PCP 8/12 about the dizziness, where she was given a chest x ray and bloodwork, she was put on prednisone. Headaches and dizziness are ongoing. She has been using the oximeter 97 is the lowest it's been. Still using the Zofran for nausea but hasn't used it in a few days. She deals with hypothyroidism and is on medication for that.
Pt was 17 years and 8 months old at the time of receiving the first dose; A spontaneous report was received from a physician concerning a 17-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and patient was 17 years and 8 months old at the time of receiving the first dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot: 025L20A) intramuscularly for prophylaxis of COVID-19. The patient was 17 years and 8 months old at the time of receiving the first dose. No side effects to vaccine were reported.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome for the event, patient was 17 years and 8 months old at the time of receiving the first dose, was resolved on 30 Dec 2020.; Reporter's Comments: This case concerns a 17-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot: 025L20A), reporting Product administered to patient of inappropriate age.
This spontaneous report as received from a pharmacist via company representative refers to a male patient of unknown age. The patient had no pertinent medical history, drug reactions or allergies. On an unknown date, the patient was vaccinated with a dose of ZOSTACAX (dose, lot number and expiry date were not reported). There was no concomitant medication provided. On an unknown date, the patient experienced unspecified reaction. The patient sought medical attention and saw a physician (name unspecified). The outcome of unspecified reaction was reported as resolved (unspecified date). The relatedness between the event above mentioned and ZOSTAVAX was not provided. This is one of two reports received from the same reporter. Additional information has been requested.
Tested positive for COVID after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID after vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID after vaccination). At the time of the report, COVID-19 (Tested positive for COVID after vaccination) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     No concomitant medication provided.
His father died just after receiving the vaccine; Patient experienced tremors on his hands just after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (His father died just after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEATH (His father died just after receiving the vaccine) (seriousness criteria death and medically significant) and TREMOR (Patient experienced tremors on his hands just after getting the vaccine). The patient died on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, TREMOR (Patient experienced tremors on his hands just after getting the vaccine) outcome was unknown.            No concomitant medication details were provided. No treatment medication details were provided.  On an unknown date, patient died just after receiving the vaccine. After getting the vaccine, patient started to experience tremors on hands and doctors finished with patient at the hospital, where patient died.  Reporter was hoping this should be covered up by Moderna, also was very upset and abruptly hung up before agent could ask for any detail on the case. Company comment This spontaneous fatal case concerns a male patient of an unknown age, with no reported medical history, who experienced the unexpected serious event of DEATH, and the unexpected non-serious event of tremor. On an unknown date, patient experienced tremors on his hands just after receiving a dose of mRNA-1273 vaccine (unknown number and schedule). Doctors finished with patient at the hospital, where patient died. The cause of death was not reported. It is unknown if an autopsy was performed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous fatal case concerns a male patient of an unknown age, with no reported medical history, who experienced the unexpected serious event of DEATH, and the unexpected non-serious event of tremor. On an unknown date, patient experienced tremors on his hands just after receiving a dose of mRNA-1273 vaccine (unknown number and schedule). Doctors finished with patient at the hospital, where patient died. The cause of death was not reported. It is unknown if an autopsy was performed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death
Patient developed chest pain and difficulty breathing when lying down; symptoms started at 7pm on 5/21/2021.  Seen in the emergency room at Hospital  for chest pain, found to have elevated troponin level of 11.6 ng/mL (normal <0.05).  CT chest negative for pulmonary embolism.  Patient transferred to Medical Center.  Initial high sensitivity Troponin-T level 1224 ng/L (normal <15), BNP 805 pg/mL (nl <300).  EKG with diffuse ST segment changes.  Echocardiogram (5/23 AM) with normal systolic and diastolic function, LVEF 58%; no pericardial effusion, no pathologic valve regurgitation.  Patient admitted to telemetry monitoring bed (no arrhythmias noted during hospitalization). Patient treated initially with Ibuprofen 400 mg PO q6 hours and famotidine 20 mg PO q12 hours for presumed myopericarditis.  Workup sent for viral causes of myocarditis: Respiratory viral panel negative.  Infectious Myocarditis workup sent: CMV, Cocksakievirus A and B antibody, CMV IgG/IgM, Echovirus antibody, Infectious Mononucleosis Screen, Lyme C6 AB IgG/IgM, Mycoplasma IgG/IgM, Parvo IgG/IgM, Varicella IgG/IgM.   Follow-up echocardiogram on 5/23 (PM) and 5/24 (AM) demonstrated no change in LV systolic or diastolic function.   Cardiac enzymes, including high-sensitivity troponin T, CK and CKMB, were trended. Cardiac MRI was performed - preliminary results show evidence of myocarditis Lab Trends (earliest to most recent, as of 1 pm on 5/25/2021):  High sensitivity Troponin T: 1224, 732, 664, 1058, 1332, 1141  CKMB: 65.6, 41.6, 19.3, 11.4, 6.3, 3.2  Pro-NT-BNP: 803,493, 392, 293  CRP: 58.2, 32.8, 28.6, 14.9.   At the time of sumission of this report, the patient remains in the hospital. Further results will be communicated to VAERS.
Menstruation 7 days longer than normal. 14 days long menstruation. Period started on the date of the 3rd vaccine booster and ended 14 days later. However normal is 7 days for me
Rash/Rash and Itching all over her skin was reported as worsened; Itching/Rash and Itching all over her skin was reported as worsened; Skin is very irritated/Skin is very irritated was reported as worsened; Kind of an allergic reaction; This is a spontaneous report from a contactable consumer (patient's mother) reported for a patient (reporter's daughter). A 17-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER8736, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 08May2021 at 09:30 am (age at vaccination was 17 years) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. The patient's family history relevant to adverse event included the patient's mother had asthma. Concomitant medications included naproxen sodium (ALEVE), paracetamol (TYLENOL) and gramicidin, neomycin sulfate, polymyxin b sulfate (NEOSPORINE) all taken for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0153, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 17Apr2021 (age at vaccination was 17 years) as dose 1, single for COVID-19 immunization and had no reaction after the first dose of the COVID 19 Vaccine. No additional vaccines were administered on same date of the Pfizer suspect. The facility where the most recent COVID-19 vaccine was administered was Community Center. The vaccine was not administered at other Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08May2021 about 11:00 am to 12:00 pm, about an hour or two after the vaccine the patient complained of itching and got a rash later that day. The patient had rash and itching all over her skin. Rash and itching all over her skin was reported as worsened. It had gotten worse over time. It was not severe. On 08May2021, the patient's skin was very irritated and the patient had a kind of an allergic reaction. The patient woke up that morning with complaints of the skin irritations being worse. Skin was very irritated was reported as worsened. It was not critical, the patient's skin was just very irritated. Prior to the second dose of the COVID 19 Vaccine the patient had no itching or rashes. She was trying to find information on skin reactions but could not find any information. She wanted information on this and how long it lasts and what to do about it. The patient was referred to HCP for further discussion and treatment recommendations. The reporter denied any medications, medical conditions, labs, testing or treatments for the patient that are relevant to these events. The adverse events did not require a visit to Emergency Room or Physician Office. No relevant tests were done. The outcome of the event kind of an allergic reaction was unknown. The outcome of the other events was not resolved.  No follow-up attempts are needed. No further information is expected
Pt was given oral Rota at 8 months of age. Rota needs to be given between 6-32 weeks only.
Pt describes neck pain starting 3 days after injection which radiates to Left arm and has cause weakness. Has done massage therapy and seen nurtritionist for event and has not helped.  Injection was given 10/18/07 in the right deltoid.Did not report fever or any other symptoms.
Throat tightening; fever; ear,  jaw & neck muscle pain & stiffness on right side of body; glassy eyes w/contracted pupils. At 3:22 pm Took BC max strength powder: containing Acetaminophen 500mg Aspirin NSAID 500mg Caffeine 65mg Throat  tightness lessened around  3:45pm Fever broke at approximately 6:30pm   Neck  Jaw Ear pain & stiffness subsided approximately 24 hrs after onset.
Itchy rash erupted on left arm one week after injection. It was about 4 inches long and 3 inches wide. It started as raised red dots and then became a connected patch. I applied an ant-itch cream (2% diphenhydramine and 0.1% zinc acetate) It appears to be getting better after 2 days.
Vaccine given at 8:30 or 9AM. At about 2 pm began crying, nonstop until nearly 6pm, then slept.  I examined baby at 7:30pm-about interaction and apparently recovered.